Atrial Fibrillation Also called: AF, AFib

Clinical Trial Finder

Many patients with atrial fibrillation are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban

Conditions:   Cerebrovascular Stroke;   Intracranial Hemorrhages;   Anticoagulant;   Matrix Metalloproteinases
Intervention:   Drug: Rivaroxaban
Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Bayer
Not yet recruiting

Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias

Conditions:   Atrial Fibrillation;   Arrhythmias, Cardiac;   Atrial Flutter
Intervention:   Device: Ambulatory ECG
Sponsor:   Apple Inc.
Enrolling by invitation

Evaluation of the Added Value of an Internet-based Educational Program for Patients With Atrial Fibrillation.

Conditions:   Atrial Fibrillation;   Quality of Life;   Signs and Symptoms;   Health Economy
Intervention:   Other: Internet-based education
Sponsors:   Ulla Walfridsson;   Dept of Internal Medicin, County Hospital Ryhov, Jönköping, Sweden.;   Dept of Cardiology, Örebro University Hospital, Sweden
Recruiting

Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke

Conditions:   Stroke;   Atrial Fibrillation
Interventions:   Device: Testing Devices;   Device: CardioKey device by Biotel
Sponsors:   University of Massachusetts, Worcester;   University of Connecticut;   Northeastern University;   Brigham and Women's Hospital;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting

Evaluation of Safety and Effectiveness on Oral Anticoagulants

Condition:   Atrial Fibrillation
Intervention:   Other: Non-Interventional
Sponsors:   Bristol-Myers Squibb;   Pfizer
Active, not recruiting

Ultra-High-Resolution Mapping Guided Partial Antral Ablation for AF

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   Keimyung University Dongsan Medical Center;   Boston Scientific Corporation
Recruiting

Atrial Fibrillation Research Database

Conditions:   Anticoagulants and Bleeding Disorders;   Atrial Fibrillation
Intervention:  
Sponsors:   University of Campania "Luigi Vanvitelli";   Monaldi Hospital
Recruiting

Inflammation, Fibrosis and Risk of Recurrence After Atrial Fibrillation Ablation

Conditions:   Atrial Fibrillation;   Atrial Inflammation
Interventions:   Diagnostic Test: Cardiac imaging tests;   Diagnostic Test: Venous blood samle collection
Sponsors:   Cardio Med Medical Center;   University of Targu Mures, Romania;   University Hospital of Targu Mures, Romania
Not yet recruiting

ABC-Scores for Reduction of Stroke and Mortality in Atrial Fibrillation - The ABC-AF Study

Condition:   Atrial Fibrillation
Interventions:   Other: ABC score guided therapy;   Other: Standard care
Sponsors:   Uppsala University;   Swedish Foundation for Strategic Research;   Swedish Heart Lung Foundation;   Roche Diagnostics
Recruiting

OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial

Conditions:   Stroke, Acute;   Atrial Fibrillation
Intervention:   Drug: Direct oral anticoagulant (DOAC)
Sponsor:   University College, London
Not yet recruiting

Singapore Cardiac Longitudinal Outcomes Database

Conditions:   Coronary Artery Disease;   Congestive Heart Failure;   Atrial Fibrillation
Intervention:   Other: Data Collection
Sponsors:   National Heart Centre Singapore;   Ministry of Health, Singapore;   Changi General Hospital;   National University Hospital, Singapore;   Singapore General Hospital;   Tan Tock Seng Hospital;   Khoo Teck Puat Hospital;   SingHealth Polyclinics;   National Healthcare Group, Singapore;   Ng Teng Fong General Hospital
Active, not recruiting

Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation (PANACEA-AF)

Condition:   Atrial Fibrillation
Intervention:   Device: Atrial fibrillation ablation
Sponsor:   University of Chicago
Recruiting

Left Atrial Appendage Ligation Using the Atriclip Device

Condition:   Left Atrial Appendage Ligation
Intervention:   Device: exclusion of the left atrial appendage
Sponsors:   St. Helena Hospital Coon Joint Replacement Institute;   AtriCure, Inc.;   Adventist Heart and Vascular Institute
Completed

Minimally Invasive Detection of a Sleep Apnoea

Conditions:   Sleep Disorder; Breathing-Related;   Cardiovascular Diseases;   Cardiovascular Risk Factor;   Cardiovascular Complication
Intervention:   Device: Kinocardiography unintrusive recording
Sponsor:   Erasme University Hospital
Enrolling by invitation

Moderato System in Patients With Hypertension

Conditions:   Hypertension, Resistant to Conventional Therapy;   Atrioventricular Block
Interventions:   Device: BackBeat Moderato System;   Device: BackBeat Moderato Sytsem
Sponsors:   BackBeat Medical Inc;   MGH Echo Core Lab;   MLM Medical Labs GmbH;   nabios GmbH
Recruiting

LOSE-AF: Can Weight Loss Help Patients With Atrial Fibrillation?

Conditions:   Atrial Fibrillation;   Overweight and Obesity
Interventions:   Other: Meal Replacement Weight Loss Programme;   Other: Usual Care
Sponsor:   University of Oxford
Recruiting

Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization

Conditions:   Coronary Artery Disease;   Coronary Artery Angiography;   Coronary Catheterization;   Contrast-induced Nephropathy;   Stable Angina;   Acute Coronary Syndrome
Interventions:   Drug: Vitamin E;   Drug: N-acetyl cysteine;   Drug: Placebo oral capsule;   Drug: Placebos;   Drug: Normal Saline Flush, 0.9% Injectable Solution
Sponsor:   Rajaie Cardiovascular Medical and Research Center
Recruiting

Preoperative Oral Magnesium to Prevent Postoperative Atrial Fibrillation Following Coronary Surgery (POMAF-CS)

Conditions:   Atrial Fibrillation;   Coronary Artery Disease;   Surgery--Complications
Interventions:   Drug: Magnesium Sulfate;   Drug: Placebo Oral Tablet
Sponsor:   St Joseph University, Beirut, Lebanon
Recruiting

The Box 2.0: Using Smart Technology for Early Diagnosis of Complications After Cardiovascular Surgery

Conditions:   Rehabilitation After Cardiovascular Surgery;   Mobile Health
Intervention:   Other: The Box 2.0
Sponsor:   Leiden University Medical Center
Recruiting

Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up

Condition:   Atrial Fibrillation
Intervention:   Device: LAmbre occluder
Sponsor:   Lifetech Scientific (Shenzhen) Co., Ltd.
Recruiting

Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation

Condition:   Persistent Atrial Fibrillation
Intervention:   Device: TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™
Sponsor:   St. Jude Medical
Recruiting

Pharmacist and Data Driven Quality Improvement in Primary Care

Condition:   Medication Safety
Intervention:   Behavioral: P-DQIP
Sponsors:   University of Dundee;   NHS Tayside
Recruiting

Computer Scan Based Analysing System on Improving Stroke Management Quality Evaluation

Condition:   Acute Ischemic Stroke and Transient Ischemic Attacks
Intervention:   Behavioral: the response of KPI and corresponding suggestion
Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting

Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary Disease

Condition:   Pulmonary Disease, Chronic Obstructive
Intervention:   Drug: Bronchodilator Agents
Sponsor:   Università degli Studi di Ferrara
Recruiting

Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation

Condition:   Non-valvular Atrial Fibrillation
Intervention:  
Sponsor:   Pfizer
Completed

Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea

Condition:   Atrial Fibrillation
Interventions:   Drug: Apixaban;   Drug: Dabigatran;   Drug: Rivaroxaban;   Drug: warfarin;   Drug: Antiplatelets
Sponsor:   Pfizer
Active, not recruiting

Spironolactone and Perioperative Atrial Fibrillation Occurrence in Cardiac Surgery Patients.

Conditions:   Cardiac Surgery;   Atrial Fibrillation;   Aldosterone Blockade
Interventions:   Drug: Spironolactone 25mg;   Drug: Placebo oral capsule
Sponsors:   University Hospital, Caen;   Ministry of Health, France
Recruiting

Medtronic Terminate AF Study

Conditions:   Persistent Atrial Fibrillation;   Longstanding Persistent Atrial Fibrillation
Interventions:   Procedure: Surgical Ablation;   Device: Cardioblate and Cryoflex hand held devices
Sponsor:   Medtronic Cardiovascular
Recruiting

New-Onset Atrial Fibrillation Complicating Myocardial Infarction in ShangHai

Conditions:   Atrial Fibrillation;   Myocardial Infarction
Intervention:   Device: cardiac monitoring
Sponsor:   Shanghai 10th People's Hospital
Recruiting

Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement

Condition:   Aortic Stenosis
Interventions:   Device: TAVR;   Other: Warfarin plus Aspirin;   Other: Aspirin Only
Sponsor:   Medstar Health Research Institute
Recruiting

Characterization and Prediction of Atrial Fibrillation-caused Adverse Events After Hospital Discharge for Cardiac Surgery

Conditions:   Atrial Fibrillation;   Stroke, Acute;   Death
Intervention:   Procedure: Cardiac surgery
Sponsors:   Beth Israel Deaconess Medical Center;   Massachusetts General Hospital;   Baystate Medical Center;   Cape Cod Hospital;   Mount Auburn Hospital;   Memorial University Medical Center;   Tufts Medical Center;   Saint Elizabeth's Medical Center;   SouthCoast Medical Group
Active, not recruiting

Ev-AIFIB Preliminary Evaluation of the AIFib Software

Condition:   Software Performance Evaluation a Posteriori
Intervention:   Diagnostic Test: the intraoperative effectiveness of the AIFIB software in real time in the detection of atrial fibrillation drivers during an ablation procedure.
Sponsor:   Hospital St. Joseph, Marseille, France
Recruiting

AcQMap Objectively Visualize the Etiology of Recurrent AF Following a Failed AF Ablation

Condition:   Recurrent Atrial Fibrillation
Intervention:   Device: AcQMap Imaging and Mapping System
Sponsor:   Acutus Medical
Recruiting

High Density Scar Guided Atrial Fibrillation Mapping

Condition:   Atrial Fibrillation
Intervention:   Device: Mapping and ablation
Sponsors:   University Hospital Southampton NHS Foundation Trust;   Boston Scientific Corporation
Not yet recruiting

Low Voltage-Directed Catheter Ablation for Atrial Fibrillation

Condition:   Atrial Fibrillation - Symptomatic
Intervention:   Procedure: Radiofrequency ablation
Sponsors:   Ohad Ziv;   Biosense Webster, Inc.
Recruiting

Model Based Fast Anatomical Mapping

Conditions:   Paroxysmal Atrial Fibrillation;   Persistent Atrial Fibrillation
Intervention:   Device: MFAM
Sponsors:   Vivek Reddy;   Biosense Webster, Inc.
Enrolling by invitation

This Study Looks at the Effects of Idarucizumab in Patients Who Take Dabigatran and Need Emergency Surgery or Are Bleeding

Condition:   Atrial Fibrillation
Intervention:   Drug: Idarucizumab
Sponsor:   Boehringer Ingelheim
Recruiting

A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)

Condition:   Heart Failure With Preserved Ejection Fraction
Interventions:   Drug: IW-1973;   Drug: Placebo Oral Tablet
Sponsor:   Ironwood Pharmaceuticals, Inc.
Recruiting

Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation

Conditions:   Atrial Fibrillation;   Recurrence
Interventions:   Drug: Ranolazine plus Metoprolol Combination;   Drug: FlecainidE pluS Metoprolol Combination
Sponsor:   Elpen Pharmaceutical Co. Inc.
Withdrawn

Patient Characteristics and Treatment Modalities in COPD Patients in China

Condition:   Pulmonary Disease, Chronic Obstructive
Intervention:  
Sponsor:   GlaxoSmithKline
Recruiting

Real-world Use and Prognosis of Beta Blocker in Patients With Acute Coronary Syndrome in the Central China

Condition:   Acute Coronary Syndrome
Intervention:  
Sponsor:   Henan Institute of Cardiovascular Epidemiology
Recruiting

Assessment of Myocardial Ischemic-Reperfusion Injury During Off- and On- Pump CABG

Conditions:   Ischemic Heart Disease;   Coronary Artery Disease;   Ischemic Reperfusion Injury;   CABG
Interventions:   Procedure: On-Pump CABG.;   Procedure: Off-Pump CABG.;   Procedure: BH-CABG MSC.
Sponsor:   St. Petersburg State Pavlov Medical University
Recruiting

Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure

Condition:   Heart Failure
Interventions:   Other: Digital Engagement;   Other: Direct Engagement
Sponsors:   Duke University;   Duke Clinical Research Institute
Recruiting

Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation

Conditions:   Atrial Fibrillation;   End Stage Renal Disease
Interventions:   Drug: apixaban;   Drug: warfarin
Sponsors:   Christopher Granger, MD;   Bristol-Myers Squibb
Recruiting

A Digital Non-interventional Atrial Fibrillation (AF) Screening Study With Commercial Pulse Detection Systems

Condition:   Atrial Fibrillation
Interventions:   Device: 12-point-ECG;   Device: Polar V800;   Device: 360° eMotion FAROS SET + Belt;   Device: Adidas Micoach smart run;   Device: TomTom Runner Cardio HRM
Sponsor:   Bayer
Recruiting

Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Condition:   Atrial Fibrillation
Interventions:   Drug: Edoxaban;   Drug: Clopidogrel;   Drug: Prasugrel;   Drug: ticagrelor
Sponsor:   Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Active, not recruiting

Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation

Condition:   Persistent Atrial Fibrillation
Intervention:   Device: AcQMap System
Sponsor:   Acutus Medical
Completed

Scandinavian Multicenter Study to Advance Risk Stratification in Heart Disease- Ventricular Arrhythmias

Conditions:   Ventricular Arrhythmias;   Implantable Defibrillator User;   Biological Markers;   Heart Disease
Intervention:  
Sponsors:   University Hospital, Akershus;   Helse Stavanger HF;   University of Oslo
Recruiting

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

Condition:   Stroke
Intervention:   Drug: Rivaroxaban (Xarelto, BAY 59-7939)
Sponsors:   Bayer;   Janssen Scientific Affairs, LLC
Recruiting

Arrhythmia Detection In Obstructive Sleep Apnea (ADIOS)

Condition:   Arrhythmia Detection
Intervention:   Device: The Lifestar Act III
Sponsors:   University of Miami;   Boehringer Ingelheim
Recruiting

The Correlation Between Sleep Quality and Atrial Fibrillation Undergoing High-flow Nasal Cannula Oxygen (HFNC)

Condition:   Hypoxemia
Interventions:   Device: heated humidified high-flow nasal cannula;   Device: noninvasive ventilation
Sponsor:   Henan Institute of Cardiovascular Epidemiology
Recruiting

Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin

Condition:   Stroke, Acute
Intervention:   Device: Reveal LINQ™ Insertable Cardiac Monitor
Sponsor:   Medtronic Cardiac Rhythm and Heart Failure
Recruiting

On-pump Beating Coronary Artery Bypass Grafting by Ventricular Assist

Condition:   Coronary Artery Bypass
Interventions:   Device: left ventricular assist;   Procedure: Biventricular assist
Sponsor:   Henan Institute of Cardiovascular Epidemiology
Recruiting

APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

Condition:   Anticoagulation
Interventions:   Drug: VKA;   Drug: Apixaban;   Drug: dabigatran;   Drug: rivaroxaban
Sponsor:   Bristol-Myers Squibb
Active, not recruiting

Predictive Factors for Successful Outcome After Pulmonary Veins Ablation to Treat Paroxysmal Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:   Other: pulmonary veins ablation's successful outcome
Sponsor:   Elpen Pharmaceutical Co. Inc.
Recruiting

Feasibility Study of a Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:   Device: Aegis Sierra Ligation System
Sponsors:   Aegis Medical Innovations;   Applied Health Research Centre
Recruiting

Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation

Conditions:   Cerebral Hemorrhage;   Atrial Fibrillation
Interventions:   Drug: Apixaban;   Drug: Aspirin;   Drug: Carbasalate calcium;   Drug: Clopidogrel;   Drug: Dipyridamole;   Other: No antithrombotic treatment
Sponsors:   UMC Utrecht;   Dutch Heart Foundation;   ZonMw: The Netherlands Organisation for Health Research and Development
Recruiting

aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Device: LARIAT + PVI;   Device: Pulmonary Vein Isolation
Sponsor:   SentreHEART, Inc.
Recruiting

Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery

Condition:   Atrial Fibrillation
Interventions:   Drug: Botulinum Toxin Type A;   Drug: Placebo
Sponsors:   Joseph Mathew, M.D.;   Foundation for Anesthesia Education and Research;   American Heart Association
Active, not recruiting

Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA

Conditions:   Brain Ischemia With Non-valvular Atrial Fibrillation;   Transient Ischemic Attack With Non-valvular Atrial Fibrillation
Intervention:  
Sponsor:   University Hospital, Essen
Recruiting

Amplatzer™Amulet™ Post-Market Study

Conditions:   Atrial Fibrillation;   Thromboembolism;   Stroke
Intervention:   Device: Subjects implanted with Amulet Device
Sponsor:   St. Jude Medical
Completed

Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   Medtronic Cardiac Rhythm and Heart Failure;   IHF GmbH - Institut für Herzinfarktforschung
Active, not recruiting

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Condition:   Acute Coronary Syndromes
Interventions:   Drug: Apixaban;   Drug: vitamin K antagonist;   Drug: Acetylsalicylic acid;   Other: Acetylsalicylic acid placebo
Sponsors:   Bristol-Myers Squibb;   Pfizer;   Duke Clinical Research Institute
Completed

Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach

Conditions:   Atrial Fibrillation;   Persistent or Longstanding Persistent Atrial Fibrillation
Intervention:   Device: AtriCure Bipolar System and AtriClip® PRO LAA Exclusion System, Endocardial Ablation
Sponsor:   AtriCure, Inc.
Active, not recruiting

Cardiovascular Disease Protection Tissue

Condition:   Myocardial Ischemia
Interventions:   Procedure: Heart failure or coronary disease;   Procedure: Heart transplant patients;   Procedure: Orthotopic Heart Transplant Patients;   Procedure: Heart Surgery Patients;   Procedure: Blood Draw
Sponsors:   University of Florida;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure

Condition:   Current or Recent History of Atrial Fibrillation
Interventions:   Drug: bucindolol hydrochloride;   Drug: metoprolol succinate;   Other: Placebo oral capsule
Sponsors:   ARCA Biopharma, Inc.;   Medtronic
Completed

Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care

Conditions:   Diabetes Mellitus;   Hypertension;   Coronary Artery Disease;   Atrial Fibrillation;   Stroke
Interventions:   Other: PHCVRS Intervention;   Other: Personal Health Record
Sponsor:   Korey Kennelty
Completed

Real World Expanded Multicenter Study of the MitraClip® System (REALISM)

Conditions:   Mitral Valve Insufficiency;   Mitral Valve Regurgitation;   Mitral Valve Incompetence;   Mitral Regurgitation;   Mitral Insufficiency
Intervention:   Device: MitraClip® implant
Sponsor:   Abbott Medical Devices
Completed

ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial

Condition:   End Stage Renal Failure on Dialysis
Interventions:   Drug: Spironolactone;   Drug: Placebo
Sponsors:   University Hospital, Brest;   Central Hospital, Nancy, France;   Institut National de la Santé Et de la Recherche Médicale, France
Recruiting

REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients

Condition:   Ventricular Tachycardia
Intervention:   Device: Boston Scientific Vessix Renal Denervation System
Sponsor:   Vivek Reddy
Active, not recruiting

Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System

Condition:   Atrial Fibrillation
Intervention:   Device: Cryoablation
Sponsor:   AFreeze GmbH
Completed

Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation

Conditions:   Uncontrolled Hypertension;   Atrial Fibrillation
Intervention:   Device: Boston Scientific Vessix Renal Denervation System
Sponsor:   Vivek Reddy
Active, not recruiting

Left Atrial Appendage Occlusion Study III

Conditions:   Cardiac Surgery With Cardiopulmonary Bypass;   Atrial Fibrillation
Intervention:   Other: Left Atrial Appendage Occlusion
Sponsor:   Population Health Research Institute
Active, not recruiting

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Active, not recruiting

Warfarin - How Good Are we at Maintaining Target Range ?

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   University of Dundee;   NHS Tayside
Completed

CardioSmart Points

Log in to Check Your Balance
and Go Shopping

Learn how to earn more CardioSmart Points